Skip to content
Family HoldingAllocates capital directlyActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 9 SOURCES

Groupe Chevrillon

Also known as Chevrillon & Associés, Chevrillon & Associés SCA, Chevrillon

Paris evergreen investment company founded in 1992 by Cyrille Chevrillon, owned mainly by the Chevrillon and Besançon-Trébouta families; €30–100m equity tickets in French SMEs.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Family & background

FAMILY
Chevrillon and Besançon-Trébouta families
WEALTH ORIGIN
Laboratoires Delagrange (pharmaceuticals, now part of Sanofi), founded by the Besançon-Trébouta family
HEADQUARTERS
Paris, France
FOUNDED
1992
OUTSIDE CAPITAL
No — own capital only

Investment approach

SECTORS
Software & SaaSHealthTechConsumer & E-commerceMedia & EntertainmentIndustrial & ManufacturingFood & Agriculture
GEOGRAPHY
France
STAGES
GrowthBuyout
ROUTES
Direct investments
STRATEGIES
Direct investmentsPrivate equity
TICKET
€30M–€100M
LATEST DEAL
Codyssée (Equity stake) · Jul 2025

Overview

Groupe Chevrillon is an evergreen investment company that invests its own equity, founded in 1992 by Cyrille Chevrillon, a former banker and Gaumont executive. Its capital is held mainly by the Chevrillon and Besançon-Trébouta families; the latter founded Laboratoires Delagrange, now part of Sanofi. It takes majority or minority stakes, with or without leverage, in companies with €10–250m revenue, typically for 3–7 years. Current holdings include Heliaq, Codyssée, Culturespaces, Astrea Pharma, Arcado and myDiabby Healthcare.

Investment thesis

Growth companies or companies facing a new challenge, all sectors, revenue €10–250m; targets €30–100m of equity per deal (smaller deals possible); majority or minority, with or without leverage; holding periods typically 3–7 years or longer.

Holdings & investments (30)

  • HeliaqNOTABLE
    Software & SaaS · since 2025
  • CulturespacesNOTABLE
    Media & Entertainment · since 2022
  • AlbingiaNOTABLE
    Exited
  • PicardNOTABLE
    Consumer & E-commerce · Exited
  • Codyssée
    Software & SaaS · since 2025
  • Astrea Pharma
    Industrial & Manufacturing · since 2022
  • CFDP
    Fintech · since 2016 · Majority shareholder with IDI and Fiblac; exclusive negotiations to sell to AG2R La Mondiale (Jul 2026)
  • myDiabby Healthcare
    HealthTech
  • Arcado
    Food & Agriculture
  • DCW Éditions & Modelec
    Consumer & E-commerce
  • Deskopolitan
    Real Estate & PropTech
  • Watchfrog
    Biotech & Life Sciences
  • Myrium
    Industrial & Manufacturing · Exited 2026
  • Alain Milliat
    Consumer & E-commerce · Exited 2026 (sold to the Perrin family)
  • Dugas
    Consumer & E-commerce · Exited
  • Interflora
    Consumer & E-commerce · Exited
  • Sloclap
    Media & Entertainment · Exited
  • BCI
    Consumer & E-commerce
  • Information Services Group
  • La commune
    Consumer & E-commerce
  • Editions François Bourin
    Media & Entertainment
  • Médisup
    Education · Exited
  • BBS
    Consumer & E-commerce · Exited
  • Groupe NewLife
    Exited
  • VOIP Télécom
    Exited
  • Linagora
    Software & SaaS · Exited
  • Dupont Médical
    HealthTech · Exited
  • CPI
    Industrial & Manufacturing · Exited
  • Alkan
    Industrial & Manufacturing · Exited
  • Docali
    Exited

People

  • François de Guitaut
    Partner in charge of investments · source
  • Julien Dupont
    Chargé d'investissement · source
  • Jean-Baptiste Boucher
    Chargé d'investissement · source
  • Clément Dennaï
    Chargé d'investissement · source
  • Cyrille Chevrillon
    Founder and Chairman (Président) · source
  • Caroline Jurien de la Gravière
    Partner and CFO · source
  • Charles Best
    Partner · source
  • Élie Vannier
    Partner in charge of the European office · source
  • Paul Chevrillon
    Co-head of real estate · source
  • Nicolas Trebouta
    Chairman of the Supervisory Board · source
  • Cyril Zivré
    Conseiller de la Présidence · source
  • Olivier Missoffe
    Member of the Supervisory Board · source
  • Dorothée Pineau
    Member of the Supervisory Board · source
  • Arnaud de Boysson
    Member of the Supervisory Board · source

Classification

Family Holding. A family's holding company that owns stakes in several separate businesses or invests beyond its own group, without calling itself a family office. How family capital is classified →

FAQ

Groupe Chevrillon is a family holding based in Paris, France, founded in 1992.

Groupe Chevrillon invests on behalf of the Chevrillon and Besançon-Trébouta families family (Laboratoires Delagrange (pharmaceuticals, now part of Sanofi), founded by the Besançon-Trébouta family).

Groupe Chevrillon invests directly in companies. Its stated asset mix includes direct investments and private equity.

Groupe Chevrillon invests at Growth and Buyout stages in Software & SaaS, HealthTech, Consumer & E-commerce, Media & Entertainment, Industrial & Manufacturing and Food & Agriculture.

Groupe Chevrillon's stated ticket size is €30M–€100M.

Key people at Groupe Chevrillon include Cyrille Chevrillon (Founder and Chairman (Président)), Caroline Jurien de la Gravière (Partner and CFO), François de Guitaut (Partner in charge of investments) and Charles Best (Partner).

Groupe Chevrillon's holdings and investments include Heliaq, Culturespaces, Albingia, Picard, Codyssée, myDiabby Healthcare, Arcado and Astrea Pharma, among others.

The most recent publicly reported investment by Groupe Chevrillon is Codyssée (Equity stake), announced in Jul 2025.

No. Groupe Chevrillon invests its own capital and does not raise money from outside investors.